+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pleurodynia Treatment Market - Global Forecast 2025-2030- Product Image
Pleurodynia Treatment Market - Global Forecast 2025-2030- Product Image
Sale

Pleurodynia Treatment Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 193 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5715698
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Pleurodynia Treatment Market is evolving rapidly, presenting pharmaceutical leaders and healthcare stakeholders with informed strategic opportunities as clinical approaches shift and new industry pressures emerge. Executives considering entry, expansion, or innovation in pleurodynia care benefit from a decision-ready overview grounded in comprehensive market segmentation and competitive intelligence.

Market Snapshot: Pleurodynia Treatment Market Growth and Demand Drivers

The Pleurodynia Treatment Market grew from USD 145.40 million in 2024 to USD 153.87 million in 2025. It is expected to continue growing at a CAGR of 5.77%, reaching USD 203.65 million by 2030. This sustained growth reflects the increasing clinical recognition of pleurodynia and the expanding need for effective patient management. Market progression is propelled by advancements in diagnostic tools, the emergence of targeted antiviral treatments, and evolving healthcare delivery models. The combination of these elements is setting the stage for more innovative therapeutic strategies and creating openings for new entrants and established players alike.

Pleurodynia Treatment Market Scope & Segmentation

This report provides a detailed examination of market dynamics, capturing key segmentation dimensions and regional influences shaping access and adoption.

  • Treatment Class: Includes analgesics (NSAIDs, opioid analgesics), antipyretics (ibuprofen, paracetamol), antivirals, and combination therapies that target virus-related symptoms and underlying causes.
  • Dosage Form: Comprises injectables (prefilled syringes, vials), suspensions, syrups and solutions, and solid formats (capsules, tablets) tailored for diverse patient needs and care environments.
  • Distribution Channel: Encompasses hospital pharmacies (government and private), online pharmacies (e-marketplaces, pharmaceutical e-retailers), and retail pharmacies (chain and independent), ensuring broad and reliable treatment availability.
  • End User: Spans ambulatory surgery centers, clinics (general and specialty), home care (caregiver and self-administration), and hospitals (government and private), responding to different care pathways and provider models.
  • Region: Coverage includes the Americas (with deep dives into the U.S., Canada, Mexico, Brazil, Argentina, and specific U.S. states), Europe, Middle East & Africa (featuring key markets such as the United Kingdom, Germany, France, Russia, Italy, among others), and Asia-Pacific (notably China, India, Japan, Australia, Korea, Indonesia, and additional emerging economies).
  • Key Companies: Focuses on leading organizations such as Johnson & Johnson, Bayer Aktiengesellschaft, Reckitt Benckiser Group plc, Haleon plc, Sanofi S.A., GlaxoSmithKline plc, Novartis AG, Teva Pharmaceutical Industries Ltd., Viatris Inc., and Endo International plc.

Pleurodynia Treatment Market: Key Takeaways for Decision-Makers

  • Symptomatic relief remains a clinical cornerstone, but innovations in antiviral research and diagnostics are shifting market expectations and treatment protocols.
  • Gaps in rapid diagnosis, access to next-generation antivirals, and standardized care create opportunities for product differentiation and strategic collaboration with medical and policy stakeholders.
  • Distribution channel diversification—across digital health, hospital, and retail pharmacies—broadens market reach and enhances patient access in both urban and underserved areas.
  • Regional variation in reimbursement, regulatory requirements, and healthcare infrastructure demands tailored go-to-market strategies, particularly for emerging and mature economies.
  • Partnerships across biopharma, contract research, and technology developers empower companies to drive R&D, streamline operational resilience, and manage supply volatility.
  • The industry's move toward value-based agreements and innovative contracting models aims to balance pricing pressures with demonstrated patient outcomes.

Tariff Impact: Navigating Supply Chain and Cost Structure Shifts

Recent changes in United States tariff policy have presented cost and supply chain challenges for manufacturers and distributors of pleurodynia treatments. Organizations are re-evaluating sourcing strategies—considering alternatives to traditional suppliers and weighing the benefits of regional manufacturing. The ongoing need to control costs and assure product continuity has made risk-sharing collaborations and regulatory transparency increasingly crucial. These dynamics also reshape pricing negotiations and support the adoption of value-based reimbursement models to preserve accessibility and market presence.

Methodology & Data Sources

This report employs a multi-stage research approach combining extensive secondary data review with primary consultations from industry experts, supply chain professionals, and payers. Triangulation techniques ensure analytical rigor, and continual validation minimizes bias, resulting in a robust, decision-relevant intelligence base.

Why This Report Matters for Senior Executives

  • Supports evidence-driven investment and portfolio strategy in a dynamic therapeutic landscape.
  • Equips leaders to proactively address supply chain, regulatory, and pricing challenges through real-time competitive intelligence and market monitoring.
  • Informs localization of engagement strategies and product launches by clarifying nuanced regional and channel dynamics specific to pleurodynia treatment.

Conclusion

The pleurodynia treatment market is advancing through collaboration, technological adoption, and strategic adaptation. Leaders leveraging these insights can optimize operations, expand access, and drive meaningful clinical and commercial outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Implementation of targeted antiviral therapy regimens to reduce Coxsackievirus-induced chest pain in pleurodynia patients
5.2. Development of monoclonal antibody biologics aimed at modulating inflammatory markers in acute pleurodynia episodes
5.3. Expansion of telehealth-driven remote patient monitoring protocols for managing recurrent pleurodynia pain flares during epidemics
5.4. Strategic collaborations between biotech firms and academic institutions to accelerate vaccine candidates against Coxsackievirus B
5.5. Rising demand for combination therapy approaches integrating antiviral and analgesic agents to improve pleurodynia treatment outcomes
5.6. Adoption of real-world evidence platforms to evaluate long-term safety and efficacy of novel pleurodynia therapeutics in diverse populations
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Pleurodynia Treatment Market, by Treatment Class
8.1. Introduction
8.2. Analgesics
8.2.1. NSAIDs
8.2.2. Opioid Analgesics
8.3. Antipyretics
8.3.1. Ibuprofen
8.3.2. Paracetamol
8.4. Antivirals
8.5. Combination Therapies
9. Pleurodynia Treatment Market, by Dosage Form
9.1. Introduction
9.2. Injectables
9.2.1. Prefilled Syringes
9.2.2. Vials
9.3. Suspensions
9.4. Syrups And Solutions
9.4.1. Solutions
9.4.2. Syrups
9.5. Tablets And Capsules
9.5.1. Capsules
9.5.2. Tablets
10. Pleurodynia Treatment Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.2.1. Government Hospital Pharmacies
10.2.2. Private Hospital Pharmacies
10.3. Online Pharmacies
10.3.1. E-Marketplaces
10.3.2. Pharmaceutical E-Retailers
10.4. Retail Pharmacies
10.4.1. Chain Pharmacies
10.4.2. Independent Pharmacies
11. Pleurodynia Treatment Market, by End User
11.1. Introduction
11.2. Ambulatory Surgery Centers
11.3. Clinics
11.3.1. General Practice
11.3.2. Specialty
11.4. Home Care
11.4.1. Caregiver Administration
11.4.2. Self Administration
11.5. Hospitals
11.5.1. Government
11.5.2. Private
12. Americas Pleurodynia Treatment Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Pleurodynia Treatment Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Pleurodynia Treatment Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Johnson & Johnson
15.3.2. Bayer Aktiengesellschaft
15.3.3. Reckitt Benckiser Group plc
15.3.4. Haleon plc
15.3.5. Sanofi S.A.
15.3.6. GlaxoSmithKline plc
15.3.7. Novartis AG
15.3.8. Teva Pharmaceutical Industries Ltd.
15.3.9. Viatris Inc.
15.3.10. Endo International plc
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. PLEURODYNIA TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY TREATMENT CLASS, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY TREATMENT CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PLEURODYNIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS PLEURODYNIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PLEURODYNIA TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES PLEURODYNIA TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PLEURODYNIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PLEURODYNIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC PLEURODYNIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC PLEURODYNIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. PLEURODYNIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. PLEURODYNIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. PLEURODYNIA TREATMENT MARKET: RESEARCHAI
FIGURE 24. PLEURODYNIA TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 25. PLEURODYNIA TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 26. PLEURODYNIA TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PLEURODYNIA TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY TREATMENT CLASS, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY TREATMENT CLASS, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY ANALGESICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY NSAIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY NSAIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY OPIOID ANALGESICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY OPIOID ANALGESICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY ANTIPYRETICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY ANTIPYRETICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY IBUPROFEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY IBUPROFEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY PARACETAMOL, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY PARACETAMOL, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY ANTIPYRETICS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY ANTIPYRETICS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY ANTIVIRALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY ANTIVIRALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY COMBINATION THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY COMBINATION THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY INJECTABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY PREFILLED SYRINGES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY PREFILLED SYRINGES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY VIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY VIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY INJECTABLES, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY INJECTABLES, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY SUSPENSIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY SUSPENSIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY SYRUPS AND SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY SYRUPS AND SOLUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY SOLUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY SYRUPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY SYRUPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY SYRUPS AND SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY SYRUPS AND SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY TABLETS AND CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY TABLETS AND CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY TABLETS AND CAPSULES, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY TABLETS AND CAPSULES, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY GOVERNMENT HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY GOVERNMENT HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY PRIVATE HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY PRIVATE HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY E-MARKETPLACES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY E-MARKETPLACES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY PHARMACEUTICAL E-RETAILERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY PHARMACEUTICAL E-RETAILERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY GENERAL PRACTICE, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY GENERAL PRACTICE, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY SPECIALTY, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY SPECIALTY, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY CAREGIVER ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY CAREGIVER ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY GOVERNMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY GOVERNMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY PRIVATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY PRIVATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL PLEURODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS PLEURODYNIA TREATMENT MARKET SIZE, BY TREATMENT CLASS, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS PLEURODYNIA TREATMENT MARKET SIZE, BY TREATMENT CLASS, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS PLEURODYNIA TREATMENT MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS PLEURODYNIA TREATMENT MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS PLEURODYNIA TREATMENT MARKET SIZE, BY ANTIPYRETICS, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS PLEURODYNIA TREATMENT MARKET SIZE, BY ANTIPYRETICS, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS PLEURODYNIA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS PLEURODYNIA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS PLEURODYNIA TREATMENT MARKET SIZE, BY INJECTABLES, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS PLEURODYNIA TREATMENT MARKET SIZE, BY INJECTABLES, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS PLEURODYNIA TREATMENT MARKET SIZE, BY SYRUPS AND SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS PLEURODYNIA TREATMENT MARKET SIZE, BY SYRUPS AND SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS PLEURODYNIA TREATMENT MARKET SIZE, BY TABLETS AND CAPSULES, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS PLEURODYNIA TREATMENT MARKET SIZE, BY TABLETS AND CAPSULES, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS PLEURODYNIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS PLEURODYNIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS PLEURODYNIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS PLEURODYNIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS PLEURODYNIA TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS PLEURODYNIA TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS PLEURODYNIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS PLEURODYNIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS PLEURODYNIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS PLEURODYNIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS PLEURODYNIA TREATMENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS PLEURODYNIA TREATMENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS PLEURODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS PLEURODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS PLEURODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS PLEURODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS PLEURODYNIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS PLEURODYNIA TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES PLEURODYNIA TREATMENT MARKET SIZE, BY TREATMENT CLASS, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES PLEURODYNIA TREATMENT MARKET SIZE, BY TREATMENT CLASS, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES PLEURODYNIA TREATMENT MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES PLEURODYNIA TREATMENT MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES PLEURODYNIA TREATMENT MARKET SIZE, BY ANTIPYRETICS, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES PLEURODYNIA TREATMENT MARKET SIZE, BY ANTIPYRETICS, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES PLEURODYNIA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES PLEURODYNIA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES PLEURODYNIA TREATMENT MARKET SIZE, BY INJECTABLES, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES PLEURODYNIA TREATMENT MARKET SIZE, BY INJECTABLES, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES PLEURODYNIA TREATMENT MARKET SIZE, BY SYRUPS AND SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES PLEURODYNIA TREATMENT MARKET SIZE, BY SYRUPS AND SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES PLEURODYNIA TREATMENT MARKET SIZE, BY TABLETS AND CAPSULES, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES PLEURODYNIA TREATMENT MARKET SIZE, BY TABLETS AND CAPSULES, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES PLEURODYNIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES PLEURODYNIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES PLEURODYNIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES PLEURODYNIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES PLEURODYNIA TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES PLEURODYNIA TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES PLEURODYNIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES PLEURODYNIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES PLEURODYNIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES PLEURODYNIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES PLEURODYNIA TREATMENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES PLEURODYNIA TREATMENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES PLEURODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES PLEURODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES PLEURODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES PLEURODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES PLEURODYNIA TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES PLEURODYNIA TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 177. CANADA PLEURODYNIA TREATMENT MARKET SIZE, BY TREATMENT CLASS, 2018-2024 (USD MILLION)
TABLE 178. CANADA PLEURODYNIA TREATMENT MARKET SIZE, BY TREATMENT CLASS, 2025-2030 (USD MILLION)
TABLE 179. CANADA PLEURODYNIA TREATMENT MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 180. CANADA PLEURODYNIA TREATMENT MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 181. CANADA PLEURODYNIA TREATMENT MARKET SIZE, BY ANTIPYRETICS, 2018-2024 (USD MILLION)
TABLE 182. CANADA PLEURODYNIA TREATMENT MARKET SIZE, BY ANTIPYRETICS, 2025-2030 (USD MILLION)
TABLE 183. CANADA PLEURODYNIA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 184. CANADA PLEURODYNIA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 185. CANADA PLEURODYNIA TREATMENT MARKET SIZE, BY INJECTABLES, 2018-2024 (USD MILLION)
TABLE 186. CANADA PLEURODYNIA TREATMENT MARKET SIZE, BY INJECTABLES, 2025-2030 (USD MILLION)
TABLE 187. CANADA PLEURODYNIA TREATMENT MARKET SIZE, BY SYRUPS AND SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 188. CANADA PLEURODYNIA TREATMENT MARKET SIZE, BY SYRUPS AND SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 189. CANADA PLEURODYNIA TREATMENT MARKET SIZE, BY TABLETS AND CAPSULES, 2018-2024 (USD MILLION)
TABLE 190. CANADA PLEURODYNIA TREATMENT MARKET SIZE, BY TABLETS AND CAPSULES, 2025-2030 (USD MILLION)
TABLE 191. CANADA PLEURODYNIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 192. CANADA PLEURODYNIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 193. CANADA PLEURODYNIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 194. CANADA PLEURODYNIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 195. CANADA PLEURODYNIA TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 196. CANADA PLEURODYNIA TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 197. CANADA PLEURODYNIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 198. CANADA PLEURODYNIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 199. CANADA PLEURODYNIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. CANADA PLEURODYNIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. CANADA PLEURODYNIA TREATMENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 202. CANADA PLEURODYNIA TREATMENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 203. CANADA PLEURODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 204. CANADA PLEURODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 205. CANADA PLEURODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 206. CANADA PLEURODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 207. MEXICO PLEURODYNIA TREATMENT MARKET SIZE, BY TREATMENT CLASS, 2018-2024 (USD MILLION)
TABLE 208. MEXICO PLEURODYNIA TREATMENT MARKET SIZE, BY TREATMENT CLASS, 2025-2030 (USD MILLION)
TABLE 209. MEXICO PLEURODYNIA TREATMENT MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 210. MEXICO PLEURODYNIA TREATMENT MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 211. MEXICO PLEURODYNIA TREATMENT MARKET SIZE, BY ANTIPYRETICS, 2018-2024 (USD MILLION)
TABLE 212. MEXICO PLEURODYNIA TREATMENT MARKET SIZE, BY ANTIPYRETICS, 2025-2030 (USD MILLION)
TABLE 213. MEXICO PLEURODYNIA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 214. MEXICO PLEURODYNIA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 215. MEXICO PLEURODYNIA TREATMENT MARKET SIZE, BY INJECTABLES, 2018-2024 (USD MILLION)
TABLE 216. MEXICO PLEURODYNIA TREATMENT MARKET SIZE, BY INJECTABLES, 2025-2030 (USD MILLION)
TABLE 217. MEXICO PLEURODYNIA TREATMENT MARKET SIZE, BY SYRUPS AND SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 218. MEXICO PLEURODYNIA TREATMENT MARKET SIZE, BY SYRUPS AND SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 219. MEXICO PLEURODYNIA TREATMENT MARKET SIZE, BY TABLETS AND CAPSULES, 2018-2024 (USD MILLION)
TABLE 220. MEXICO PLEURODYNIA TREATMENT MARKET SIZE, BY TABLETS AND CAPSULES, 2025-2030 (USD MILLION)
TABLE 221. MEXICO PLEURODYNIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. MEXICO PLEURODYNIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. MEXICO PLEURODYNIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 224. MEXICO PLEURODYNIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 225. MEXICO PLEURODYNIA TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 226. MEXICO PLEURODYNIA TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 227. MEXICO PLEURODYNIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 228. MEXICO PLEURODYNIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 229. MEXICO PLEURODYNIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. MEXICO PLEURODYNIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. MEXICO PLEURODYNIA TREATMENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 232. MEXICO PLEURODYNIA TREATMENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 233. MEXICO PLEURODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 234. MEXICO PLEURODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 235. MEXICO PLEURODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 236. MEXICO PLEURODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL PLEURODYNIA TREATMENT MARKET SIZE, BY TREATMENT CLASS, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL PLEURODYNIA TREATMENT MARKET SIZE, BY TREATMENT CLASS, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL PLEURODYNIA TREATMENT MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL PLEURODYNIA TREATMENT MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL PLEURODYNIA TREATMENT MARKET SIZE, BY ANTIPYRETICS, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL PLEURODYNIA TREATMENT MARKET SIZE, BY ANTIPYRETICS, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL PLEURODYNIA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL PLEURODYNIA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL PLEURODYNIA TREATMENT MARKET SIZE, BY INJECTABLES, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL PLEURODYNIA TREATMENT MARKET SIZE, BY INJECTABLES, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL PLEURODYNIA TREATMENT MARKET SIZE, BY SYRUPS AND SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL PLEURODYNIA TREATMENT MARKET SIZE, BY SYRUPS AND SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL PLEURODYNIA TREATMENT MARKET SIZE, BY TABLETS AND CAPSULES, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL PLEURODYNIA TREATMENT MARKET SIZE, BY TABLETS AND CAPSULES, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL PLEURODYNIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL PLEURODYNIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL PLEURODYNIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL PLEURODYNIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL PLEURODYNIA TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL PLEURODYNIA TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL PLEURODYNIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL PLEURODYNIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL PLEURODYNIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL PLEURODYNIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL PLEURODYNIA TREATMENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL PLEURODYNIA TREATMENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL PLEURODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL PLEURODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL PLEURODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL PLEURODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 267. ARGENTINA PLEURODYNIA TREATMENT MARKET SIZE, BY TREATMENT CLASS, 2018-2024 (USD MILLION)
TABLE 268. ARGENTINA PLEURODYNIA TREATMENT MARKET SIZE, BY TREATMENT CLASS, 2025-2030 (USD MILLION)
TABLE 269. ARGENTINA PLEURODYNIA TREATMENT MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 270. ARGENTINA PLEURODYNIA TREATMENT MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 271. ARGENTINA PLEURODYNIA TREATMENT MARKET SIZE, BY ANTIPYRETICS, 2018-2024 (USD MILLION)
TABLE 272. ARGENTINA PLEURODYNIA TREATMENT MARKET SIZE, BY ANTIPYRETICS, 2025-2030 (USD MILLION)
TABLE 273. ARGENTINA PLEURODYNIA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 274. ARGENTINA PLEURODYNIA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 275. ARGENTINA PLEURODYNIA TREATMENT MARKET SIZE, BY INJECTABLES, 2018-2024 (USD MILLION)
TABLE 276. ARGENTINA PLEURODYNIA TREATMENT MARKET SIZE, BY INJECTABLES, 2025-2030 (USD MILLION)
TABLE 277. ARGENTINA PLEURODYNIA TREATMENT MARKET SIZE, BY SYRUPS AND SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 278. ARGENTINA PLEURODYNIA TREATMENT MARKET SIZE, BY SYRUPS AND SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 279. ARGENTINA PLEURODYNIA TREATMENT MARKET SIZE, BY TABLETS AND CAPSULES, 2018-2024 (USD MILLION)
TABLE 280. ARGENTINA PLEURODYNIA TREATMENT MARKET SIZE, BY TABLETS AND CAPSULES, 2025-2030 (USD MILLION)
TABLE 281. ARGENTINA PLEURODYNIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 282. ARGENTINA PLEURODYNIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 283. ARGENTINA PLEURODYNIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 284. ARGENTINA PLEURODYNIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 285. ARGENTINA PLEURODYNIA TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 286. ARGENTINA PLEURODYNIA TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 287. ARGENTINA PLEURODYNIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 288. ARGENTINA PLEURODYNIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA PLEURODYNIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA PLEURODYNIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA PLEURODYNIA TREATMENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 292. ARGENTINA PLEURODYNIA TREATMENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 293. ARGENTINA PLEURODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 294. ARGENTINA PLEURODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 295. ARGENTINA PLEURODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 296. ARGENTINA PLEURODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA PLEURODYNIA TREATMENT MARKET SIZE, BY TREATMENT CLASS, 2018-2024 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA PLEURODYNIA TREATMENT MARKET SIZE, BY TREATMENT CLASS, 2025-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA PLEURODYNIA TREATMENT MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA PLEURODYNIA TREATMENT MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 301. EUROPE, MIDDLE EAST & AFRICA PLEURODYNIA TREATMENT MARKET SIZE, BY ANTIPYRETICS, 2018-2024 (USD MILLION)
TABLE 302. EUROPE, MIDDLE EAST & AFRICA PLEURODYNIA TREATMENT MARKET SIZE, BY ANTIPYRETICS, 2025-2030 (USD MILLION)
TABLE 303. EUROPE, MIDDLE EAST & AFRICA PLEURODYNIA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA PLEURODYNIA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA PLEURODYNIA TREATMENT MARKET SIZE, BY INJECTABLES, 2018-2024 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA PLEURODYNIA TREATMENT MARKET SIZE, BY INJECTABLES, 2025-2030 (USD MILLION)
TABLE 307. EUROPE, MIDDLE EAST & AFRICA PLEURODYNIA TREATMENT MARKET SIZE, BY SYRUPS AND SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA PLEURODYNIA TREATMENT MARKET SIZE, BY SYRUPS AND SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA PLEURODYNIA TREATMENT MARKET SIZE, BY TABLETS AND CAPSULES, 2018-2024 (USD MILLION)
TABLE 310. EUROPE, MIDDLE EAST & AFRICA PLEURODYNIA TREATMENT MARKET SIZE, BY TABLETS AND CAPSULES, 2025-2030 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & AFRICA PLEURODYNIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 312. EUROPE, MIDDLE EAST & AFRICA PLEURODYNIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 313. EUROPE, MIDDLE EAST & AFRICA PLEURODYNIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 314. EUROPE, MIDDLE EAST & AFRICA PLEURODYNIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 315. EUROPE, MIDDLE EAST & AFRICA PLEURODYNIA TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 316. EUROPE, MIDDLE EAST & AFRICA PLEURODYNIA TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 317. EUROPE, MIDDLE EAST & AFRICA PLEURODYNIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 318. EUROPE, MIDDLE EAST & AFRICA PLEURODYNIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 319. EUROPE, MIDDLE EAST & AFRICA PLEURODYNIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 320. EUROPE, MIDDLE EAST & AFRICA PLEURODYNIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 321. EUROPE, MIDDLE EAST & AFRICA PLEURODYNIA TREATMENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 322. EUROPE, MIDDLE EAST & AFRICA PLEURODYNIA TREATMENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 323. EUROPE, MIDDLE EAST & AFRICA PLEURODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 324. EUROPE, MIDDLE EAST & AFRICA PLEURODYNIA TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 325. EUROPE, MIDDLE EAST & AFRICA PLEURODYNIA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 326. EUROPE, MIDDLE EAST & AFRICA PLEURODYNIA TRE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Pleurodynia Treatment market report include:
  • Johnson & Johnson
  • Bayer Aktiengesellschaft
  • Reckitt Benckiser Group plc
  • Haleon plc
  • Sanofi S.A.
  • GlaxoSmithKline plc
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Endo International plc

Table Information

Report AttributeDetails
No. of Pages193
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 153.87 Million
Forecasted Market Value ( USD ) by 2030 $ 203.65 Million
Compound Annual Growth Rate5.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Pleurodynia Treatment - Global Strategic Business Report - Product Image

Pleurodynia Treatment - Global Strategic Business Report

  • Report
  • 270 Pages
  • Global
From
Pleurodynia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Pleurodynia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 183 Pages
  • Global
From
Bronchial Spasms Treatment Market - Global Forecast 2025-2030 - Product Image

Bronchial Spasms Treatment Market - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Carbinoxamine maleate Market - Global Forecast 2025-2030 - Product Image

Carbinoxamine maleate Market - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Idiopathic Pulmonary Fibrosis Treatment Market Size, Share & Trends Analysis Report by Drug Class (Pirfenidone, Nintedanib), Route of Administration, Distribution Channel, Region, and Segment Forecasts, 2025-2030 - Product Image

Idiopathic Pulmonary Fibrosis Treatment Market Size, Share & Trends Analysis Report by Drug Class (Pirfenidone, Nintedanib), Route of Administration, Distribution Channel, Region, and Segment Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From

About the Pleurodynia Drug Market

Pleurodynia is a type of respiratory disorder that is characterized by chest pain and tenderness. It is caused by a virus, usually the Coxsackievirus, and is also known as “the epidemic of the summer”. Treatment for pleurodynia is mainly supportive, with the use of analgesics and anti-inflammatory drugs. In some cases, antibiotics may be prescribed to treat any secondary bacterial infections. The pleurodynia drug market is a subset of the larger respiratory drug market. It includes drugs used to treat pleurodynia, such as analgesics, anti-inflammatory drugs, and antibiotics. These drugs are used to reduce pain and inflammation, as well as to treat any secondary bacterial infections. Some companies in the pleurodynia drug market include Pfizer, Merck, GlaxoSmithKline, Novartis, and Sanofi. These companies produce a variety of drugs used to treat pleurodynia, including analgesics, anti-inflammatory drugs, and antibiotics. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.